Smith & Nephew releases new Modular Rail System in collaboration with Dr. Dror Paley

Smith & Nephew releases new Modular Rail System in collaboration with Dr. Dror
                                    Paley

PR Newswire

LONDON, March 20, 2013

LONDON, March 20, 2013 /PRNewswire/ --Smith & Nephew (LSE: SN, NYSE: SNN),
the global medical technology business, announces the introduction of a new
Modular Rail System (MRS) for external fixation and deformity correction. This
new treatment option highlights Smith & Nephew's increased investment in its
extremities and limb restoration portfolio, and its commitment to advancing
technology by working directly with surgeon inventors. 

(Photo: http://photos.prnewswire.com/prnh/20130320/CL80346)

Designed to correct bone deformities, malunions, non-unions and limb length
discrepancies, the MRS takes advantage of the body's ability to grow new bone
tissue. Using a segmented, external rail and a series of half-pins, the system
holds various bone segments in correct alignment while new bone tissue grows
and matures. Because the rail system is modular, it can be lengthened or
shortened to meet the size needs of a patient, and can be joined with
components from Smith & Nephew's TAYLOR SPATIAL FRAME™ and ILIZAROV™ circular
fixation devices. And, unlike most rail systems, this new system is able to
span a patient's joint, allowing it to bend and function normally while the
device is in place.

The surgeon expert behind the MRS concept is Dror Paley, MD, of the Paley
Advanced Limb Lengthening Institute at St. Mary's Medical Centerin West Palm
Beach, Fla.

"Over the course of my 25-plus year career, I've tried many of the available
rail systems on the market, none of which fully meet my needs," explains Dr.
Paley. "Working with Smith & Nephew, I was able to design and develop a
modular, multiplanar rail which can articulate across the hip, knee, ankle or
elbow joints while allowing for lengthening and deformity correction."

"We're excited to introduce the Modular Rail System to our surgeon customers
and their patients," says Mark Waugh, Divisional Vice President for Smith &
Nephew's Extremities and Limb Restoration business. "The new system joins our
industry-leading suite of limb restoration and deformity correction products,
which includes the TAYLOR SPATIAL FRAME external fixator."

The Modular Rail System will be among the new technologies Smith & Nephew will
highlight at this year's American Academy of Orthopedic Surgeons annual
meeting. Dr. Paley will present on the MRS at the Smith & Nephew booth (booth
#1812) on Wednesday, March 20, at 2:30 pm.

About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping
improve people's lives. With leadership positions in Orthopaedic
Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith &
Nephew has almost 10,500 employees and a presence in more than 90 countries.
Annual sales in 2012 were more than $4.1 billion. Smith & Nephew is a member
of the FTSE100 (LSE: SN, NYSE: SNN).

For more information about Smith & Nephew, please visit: www.smith-nephew.com

Forward-looking Statements
This document may contain forward-looking statements that may or may not prove
accurate. For example, statements regarding expected revenue growth and
trading margins, market trends and our product pipeline are forward-looking
statements. Phrases such as "aim", "plan", "intend", "anticipate",
"well-placed", "believe", "estimate", "expect", "target", "consider" and
similar expressions are generally intended to identify forward-looking
statements. Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual results to
differ materially from what is expressed or implied by the statements. For
Smith & Nephew, these factors include: economic and financial conditions in
the markets we serve, especially those affecting health care providers, payors
and customers; price levels for established and innovative medical devices;
developments in medical technology; regulatory approvals, reimbursement
decisions or other government actions; product defects or recalls; litigation
relating to patent or other claims; legal compliance risks and related
investigative, remedial or enforcement actions; strategic actions, including
acquisitions and dispositions, our success in integrating acquired businesses,
and disruption that may result from changes we make in our business plans or
organisation to adapt to market developments; and numerous other matters that
affect us or our markets, including those of a political, economic, business
or competitive nature. Please refer to the documents that Smith & Nephew has
filed with the U.S. Securities and Exchange Commission under the U.S.
Securities Exchange Act of 1934, as amended, including Smith & Nephew's most
recent annual report on Form 20-F, for a discussion of certain of these
factors.

Any forward-looking statement is based on information available to Smith &
Nephew as of the date of the statement. All written or oral forward-looking
statements attributable to Smith & Nephew are qualified by this caution. Smith
& Nephew does not undertake any obligation to update or revise any
forward-looking statement to reflect any change in circumstances or in Smith &
Nephew's expectations.

Trademark of Smith & Nephew. Registered US Patent and Trademark Office.

SOURCE Smith & Nephew

Website: http://www.smith-nephew.com
Contact: Andrew Burns, Media, Smith & Nephew, +1-901-399-5739,
andrew.burns@smith-nephew.com, or Phil Cowdy, Investor/Analyst, Smith &
Nephew, +44 (0)20 7401 7646, Phil.Cowdy@smith-nephew.com